Bright Minds Biosciences focuses on creating the next generation of psychedelics to treat mental health disorders. Molecules that the world has never seen and that mother nature has not thought of. The company's altering the chemical structure in order to create psychedelics drugs with minimized side effects and improved therapeutic action. Investors are funding researches and studies carried out by biotechnology companies such as Bright Minds Biosciences. This positive shift in the psychedelic space has occurred due to people becoming more aware of these compounds' possible benefits.